Crossmark

The COVID-19 pandemic as a catalyst for innovation: a regulatory framework to assess fit-for-purpose innovative approaches in clinical research

Published Online: 2022-09-30

Authors

Leyens, Lada

Simkins, Tracy

Horst, Nafsika Kronidou
Funding

Funding for this research was provided by:

F. Hoffmann-La Roche
License Information

Text and Data Mining valid from 2022-09-30

Version of Record valid from 2022-09-30
More Information

Article History

Received: 9 November 2021

Accepted: 1 September 2022

First Online: 30 September 2022

Declarations

:

: Not applicable

: All authors agreed to the submission of this manuscript for publication.

: The authors are employees and/or stock owners of F. Hoffmann–La Roche Ltd.

Document is current